$REPH Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Recro Pharma, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Recro Pharma, Inc.. Get notifications about new insider transactions in Recro Pharma, Inc. for free.

Page: < prev 1 2 3

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Dec 19 2016	REPH	Recro Pharma, Inc.	Flynn Karen	Director	Buy	P	6.71	800	5,364	800	0 to 800
Dec 16 2016	REPH	Recro Pharma, Inc.	ALTOMARI ALFRED	Director	Buy	P	6.55	1,500	9,825	1,500	0 to 1.5 K
Dec 14 2016	REPH	Recro Pharma, Inc.	Broadfin Healthcare Master Fun ...	10% Owner	Buy	P	6.00	650,000	3,900,000	3,100,086	2.5 M to 3.1 M (+26.53 %)
Dec 05 2016	REPH	Recro Pharma, Inc.	Mack Randall	Senior VP, Developm ...	Payment of Exercise	F	6.48	1,892	12,260	9,762	11.7 K to 9.8 K (-16.23 %)
Dec 05 2016	REPH	Recro Pharma, Inc.	Mack Randall	Senior VP, Developm ...	Buy	M	0.00	6,100	0	11,654	5.6 K to 11.7 K (+109.83 %)
Dec 05 2016	REPH	Recro Pharma, Inc.	Myers Diane	Director	Payment of Exercise	F	6.48	777	5,035	3,283	4.1 K to 3.3 K (-19.14 %)
Dec 05 2016	REPH	Recro Pharma, Inc.	Myers Diane	Director	Buy	M	0.00	2,500	0	4,060	1.6 K to 4.1 K (+160.26 %)
Dec 05 2016	REPH	Recro Pharma, Inc.	HENWOOD GERALDINE	Director	Option Exercise	A	8.41	52,650	442,787	105,300
Dec 05 2016	REPH	Recro Pharma, Inc.	Nichols Donna	CAO/Controller	Buy	M	0.00	2,500	0	7,340	4.8 K to 7.3 K (+51.65 %)
Nov 03 2016	REPH	Recro Pharma, Inc.	HENWOOD GERALDINE	President and CEO	Option Exercise	A	8.41	52,650	442,787	52,650
Aug 17 2016	REPH	Recro Pharma, Inc.	Broadfin Healthcare Master Fun ...	10% Owner	Buy	P	7.50	390,000	2,925,000	2,450,086	2.1 M to 2.5 M (+18.93 %)
Aug 17 2016	REPH	Recro Pharma, Inc.	Broadfin Healthcare Master Fun ...	10% Owner	Buy	P	7.50	390,000	2,925,000	2,450,086	2.1 M to 2.5 M (+18.93 %)
Aug 03 2016	REPH	Recro Pharma, Inc.	Nichols Donna	CAO/Controller	Buy	M	0.00	2,500	0	4,840	2.3 K to 4.8 K (+106.84 %)
Aug 03 2016	REPH	Recro Pharma, Inc.	Myers Diane	Senior VP-Reg/Quali ...	Payment of Exercise	F	9.70	940	9,118	1,560	2.5 K to 1.6 K (-37.60 %)
Aug 03 2016	REPH	Recro Pharma, Inc.	Myers Diane	Senior VP-Reg/Quali ...	Buy	M	0.00	2,500	0	2,500	0 to 2.5 K
Aug 03 2016	REPH	Recro Pharma, Inc.	Mack Randall	Senior VP, Developm ...	Payment of Exercise	F	9.70	2,546	24,696	5,554	8.1 K to 5.6 K (-31.43 %)
Aug 03 2016	REPH	Recro Pharma, Inc.	Mack Randall	Senior VP, Developm ...	Buy	M	0.00	6,100	0	8,100	2 K to 8.1 K (+305.00 %)
Jul 05 2016	REPH	Recro Pharma, Inc.	Celano Michael	Chief Financial Off ...	Option Exercise	A	8.21	140,000	1,149,400	140,000
Jun 02 2016	REPH	Recro Pharma, Inc.	Graff Fred	Chief Commercial Of ...	Buy	P	8.46	8,000	67,707	8,000	0 to 8 K
May 31 2016	REPH	Recro Pharma, Inc.	McCallum Stewart	Chief Medical Offic ...	Buy	P	8.50	250	2,125	1,250	1,000 to 1.3 K (+25.00 %)
May 31 2016	REPH	Recro Pharma, Inc.	McCallum Stewart	Chief Medical Offic ...	Buy	P	8.15	1,000	8,150	1,000	0 to 1,000
May 25 2016	REPH	Recro Pharma, Inc.	SCP Vitalife Partners II LP	10% Owner	Sell	S	6.30	7,497	47,232	2,322,824	2.3 M to 2.3 M (-0.32 %)
May 25 2016	REPH	Recro Pharma, Inc.	SCP Vitalife Partners (Israel) ...	10% Owner	Sell	S	6.30	2,503	15,769	776,131	778.6 K to 776.1 K (-0.32 %)
May 25 2016	REPH	Recro Pharma, Inc.	Mack Randall	Senior VP, Developm ...	Buy	P	6.30	2,000	12,600	2,000	0 to 2 K
May 23 2016	REPH	Recro Pharma, Inc.	Weisman Wayne	Director	Sell	S	6.45	5,008	32,326	778,634	783.6 K to 778.6 K (-0.64 %)
May 23 2016	REPH	Recro Pharma, Inc.	Weisman Wayne	Director	Sell	S	6.45	14,992	96,770	2,330,321	2.3 M to 2.3 M (-0.64 %)
May 23 2016	REPH	Recro Pharma, Inc.	Weisman Wayne	Director	Sell	S	6.46	1,252	8,083	783,642	784.9 K to 783.6 K (-0.16 %)
May 23 2016	REPH	Recro Pharma, Inc.	Weisman Wayne	Director	Sell	S	6.46	3,748	24,197	2,345,313	2.3 M to 2.3 M (-0.16 %)
May 23 2016	REPH	Recro Pharma, Inc.	Weisman Wayne	Director	Sell	S	9.00	150	1,350	784,894	785 K to 784.9 K (-0.02 %)
May 23 2016	REPH	Recro Pharma, Inc.	Weisman Wayne	Director	Sell	S	9.00	450	4,050	2,349,061	2.3 M to 2.3 M (-0.02 %)
May 23 2016	REPH	Recro Pharma, Inc.	Weisman Wayne	Director	Sell	S	9.00	2,250	20,252	785,044	787.3 K to 785 K (-0.29 %)
May 23 2016	REPH	Recro Pharma, Inc.	Weisman Wayne	Director	Sell	S	9.00	6,737	60,639	2,349,511	2.4 M to 2.3 M (-0.29 %)
May 23 2016	REPH	Recro Pharma, Inc.	Weisman Wayne	Director	Sell	S	9.00	1,553	13,977	787,294	788.8 K to 787.3 K (-0.20 %)
May 23 2016	REPH	Recro Pharma, Inc.	Weisman Wayne	Director	Sell	S	9.00	4,648	41,832	2,356,248	2.4 M to 2.4 M (-0.20 %)
May 23 2016	REPH	Recro Pharma, Inc.	Weisman Wayne	Director	Sell	S	9.01	691	6,223	788,847	789.5 K to 788.8 K (-0.09 %)
May 23 2016	REPH	Recro Pharma, Inc.	Weisman Wayne	Director	Sell	S	9.01	2,068	18,624	2,360,896	2.4 M to 2.4 M (-0.09 %)
May 23 2016	REPH	Recro Pharma, Inc.	Weisman Wayne	Director	Sell	S	9.00	3,702	33,321	789,538	793.2 K to 789.5 K (-0.47 %)
May 23 2016	REPH	Recro Pharma, Inc.	Weisman Wayne	Director	Sell	S	9.00	11,082	99,748	2,362,964	2.4 M to 2.4 M (-0.47 %)
May 23 2016	REPH	Recro Pharma, Inc.	LUDOMIRSKI ABRAHAM	Director	Sell	S	6.45	5,008	32,326	778,634	783.6 K to 778.6 K (-0.64 %)
May 23 2016	REPH	Recro Pharma, Inc.	LUDOMIRSKI ABRAHAM	Director	Sell	S	6.45	14,992	96,770	2,330,321	2.3 M to 2.3 M (-0.64 %)
May 23 2016	REPH	Recro Pharma, Inc.	LUDOMIRSKI ABRAHAM	Director	Sell	S	6.46	1,252	8,083	783,642	784.9 K to 783.6 K (-0.16 %)
May 23 2016	REPH	Recro Pharma, Inc.	LUDOMIRSKI ABRAHAM	Director	Sell	S	6.46	3,748	24,197	2,345,313	2.3 M to 2.3 M (-0.16 %)
May 23 2016	REPH	Recro Pharma, Inc.	LUDOMIRSKI ABRAHAM	Director	Sell	S	9.00	150	1,350	784,894	785 K to 784.9 K (-0.02 %)
May 23 2016	REPH	Recro Pharma, Inc.	LUDOMIRSKI ABRAHAM	Director	Sell	S	9.00	450	4,050	2,349,061	2.3 M to 2.3 M (-0.02 %)
May 23 2016	REPH	Recro Pharma, Inc.	LUDOMIRSKI ABRAHAM	Director	Sell	S	9.00	2,250	20,252	785,044	787.3 K to 785 K (-0.29 %)
May 23 2016	REPH	Recro Pharma, Inc.	LUDOMIRSKI ABRAHAM	Director	Sell	S	9.00	6,737	60,639	2,349,511	2.4 M to 2.3 M (-0.29 %)
May 23 2016	REPH	Recro Pharma, Inc.	LUDOMIRSKI ABRAHAM	Director	Sell	S	9.00	1,553	13,977	787,294	788.8 K to 787.3 K (-0.20 %)
May 23 2016	REPH	Recro Pharma, Inc.	LUDOMIRSKI ABRAHAM	Director	Sell	S	9.00	4,648	41,832	2,356,248	2.4 M to 2.4 M (-0.20 %)
May 23 2016	REPH	Recro Pharma, Inc.	LUDOMIRSKI ABRAHAM	Director	Sell	S	9.01	691	6,223	788,847	789.5 K to 788.8 K (-0.09 %)
May 23 2016	REPH	Recro Pharma, Inc.	LUDOMIRSKI ABRAHAM	Director	Sell	S	9.01	2,068	18,624	2,360,896	2.4 M to 2.4 M (-0.09 %)
May 23 2016	REPH	Recro Pharma, Inc.	LUDOMIRSKI ABRAHAM	Director	Sell	S	9.00	3,702	33,321	789,538	793.2 K to 789.5 K (-0.47 %)
May 23 2016	REPH	Recro Pharma, Inc.	LUDOMIRSKI ABRAHAM	Director	Sell	S	9.00	11,082	99,748	2,362,964	2.4 M to 2.4 M (-0.47 %)
May 23 2016	REPH	Recro Pharma, Inc.	CHURCHILL WINSTON J	Director	Sell	S	6.45	5,008	32,326	778,634	783.6 K to 778.6 K (-0.64 %)
May 23 2016	REPH	Recro Pharma, Inc.	CHURCHILL WINSTON J	Director	Sell	S	6.45	14,992	96,770	2,330,321	2.3 M to 2.3 M (-0.64 %)
May 23 2016	REPH	Recro Pharma, Inc.	CHURCHILL WINSTON J	Director	Sell	S	6.46	1,252	8,083	783,642	784.9 K to 783.6 K (-0.16 %)
May 23 2016	REPH	Recro Pharma, Inc.	CHURCHILL WINSTON J	Director	Sell	S	6.46	3,748	24,197	2,345,313	2.3 M to 2.3 M (-0.16 %)
May 23 2016	REPH	Recro Pharma, Inc.	CHURCHILL WINSTON J	Director	Sell	S	9.00	150	1,350	784,894	785 K to 784.9 K (-0.02 %)
May 23 2016	REPH	Recro Pharma, Inc.	CHURCHILL WINSTON J	Director	Sell	S	9.00	450	4,050	2,349,061	2.3 M to 2.3 M (-0.02 %)
May 23 2016	REPH	Recro Pharma, Inc.	CHURCHILL WINSTON J	Director	Sell	S	9.00	2,250	20,252	785,044	787.3 K to 785 K (-0.29 %)
May 23 2016	REPH	Recro Pharma, Inc.	CHURCHILL WINSTON J	Director	Sell	S	9.00	6,737	60,639	2,349,511	2.4 M to 2.3 M (-0.29 %)
May 23 2016	REPH	Recro Pharma, Inc.	CHURCHILL WINSTON J	Director	Sell	S	9.00	1,553	13,977	787,294	788.8 K to 787.3 K (-0.20 %)
May 23 2016	REPH	Recro Pharma, Inc.	CHURCHILL WINSTON J	Director	Sell	S	9.00	4,648	41,832	2,356,248	2.4 M to 2.4 M (-0.20 %)
May 23 2016	REPH	Recro Pharma, Inc.	CHURCHILL WINSTON J	Director	Sell	S	9.01	691	6,223	788,847	789.5 K to 788.8 K (-0.09 %)
May 23 2016	REPH	Recro Pharma, Inc.	CHURCHILL WINSTON J	Director	Sell	S	9.01	2,068	18,624	2,360,896	2.4 M to 2.4 M (-0.09 %)
May 23 2016	REPH	Recro Pharma, Inc.	CHURCHILL WINSTON J	Director	Sell	S	9.00	3,702	33,321	789,538	793.2 K to 789.5 K (-0.47 %)
May 23 2016	REPH	Recro Pharma, Inc.	CHURCHILL WINSTON J	Director	Sell	S	9.00	11,082	99,748	2,362,964	2.4 M to 2.4 M (-0.47 %)
May 23 2016	REPH	Recro Pharma, Inc.	SCP Vitalife Partners II LP	10% Owner	Sell	S	6.45	14,992	96,770	2,330,321	2.3 M to 2.3 M (-0.64 %)
May 23 2016	REPH	Recro Pharma, Inc.	SCP Vitalife Partners II LP	10% Owner	Sell	S	6.46	3,748	24,197	2,345,313	2.3 M to 2.3 M (-0.16 %)
May 23 2016	REPH	Recro Pharma, Inc.	SCP Vitalife Partners (Israel) ...	10% Owner	Sell	S	6.45	5,008	32,326	778,634	783.6 K to 778.6 K (-0.64 %)
May 23 2016	REPH	Recro Pharma, Inc.	SCP Vitalife Partners (Israel) ...	10% Owner	Sell	S	6.46	1,252	8,083	783,642	784.9 K to 783.6 K (-0.16 %)
May 23 2016	REPH	Recro Pharma, Inc.	Nichols Donna	CAO/Controller	Buy	P	6.48	1,140	7,387	2,340	1.2 K to 2.3 K (+95.00 %)
Feb 18 2016	REPH	Recro Pharma, Inc.	Graff Fred	Chief Commercial Of ...	Option Exercise	A	6.10	91,000	555,100	91,000
Dec 18 2015	REPH	Recro Pharma, Inc.	ALTOMARI ALFRED	Director	Option Exercise	A	8.41	10,000	84,100	10,000
Dec 18 2015	REPH	Recro Pharma, Inc.	Flynn Karen	Director	Option Exercise	A	8.41	10,000	84,100	10,000
Dec 18 2015	REPH	Recro Pharma, Inc.	Weisman Wayne	Director	Option Exercise	A	8.41	10,000	84,100	10,000
Dec 18 2015	REPH	Recro Pharma, Inc.	CHURCHILL WINSTON J	Director	Option Exercise	A	8.41	10,000	84,100	10,000
Dec 18 2015	REPH	Recro Pharma, Inc.	Ashton William	Director	Option Exercise	A	8.41	10,000	84,100	10,000
Dec 18 2015	REPH	Recro Pharma, Inc.	Berelowitz Michael	Director	Option Exercise	A	8.41	10,000	84,100	10,000
Dec 18 2015	REPH	Recro Pharma, Inc.	LUDOMIRSKI ABRAHAM	Director	Option Exercise	A	8.41	10,000	84,100	10,000
Dec 18 2015	REPH	Recro Pharma, Inc.	HENWOOD GERALDINE	President and CEO	Option Exercise	A	8.41	105,300	885,573	105,300
Dec 18 2015	REPH	Recro Pharma, Inc.	Nichols Donna	CAO/Controller	Option Exercise	A	8.41	16,000	134,560	16,000
Dec 18 2015	REPH	Recro Pharma, Inc.	Myers Diane	Senior VP-Reg/Quali ...	Option Exercise	A	8.41	18,000	151,380	18,000
Dec 18 2015	REPH	Recro Pharma, Inc.	Mack Randall	Senior VP, Developm ...	Option Exercise	A	8.41	20,000	168,200	20,000
Dec 02 2015	REPH	Recro Pharma, Inc.	McCallum Stewart	Chief Medical Offic ...	Option Exercise	A	9.29	103,000	956,870	103,000
Dec 01 2015	REPH	Recro Pharma, Inc.	SCP Vitalife Partners II LP	10% Owner	Sell	S	9.00	450	4,050	2,349,061	2.3 M to 2.3 M (-0.02 %)
Dec 01 2015	REPH	Recro Pharma, Inc.	SCP Vitalife Partners (Israel) ...	10% Owner	Sell	S	9.00	150	1,350	784,894	785 K to 784.9 K (-0.02 %)
Nov 30 2015	REPH	Recro Pharma, Inc.	SCP Vitalife Partners (Israel) ...	10% Owner	Sell	S	9.00	2,250	20,252	785,044	787.3 K to 785 K (-0.29 %)
Nov 30 2015	REPH	Recro Pharma, Inc.	SCP Vitalife Partners (Israel) ...	10% Owner	Sell	S	9.00	1,553	13,977	787,294	788.8 K to 787.3 K (-0.20 %)
Nov 30 2015	REPH	Recro Pharma, Inc.	SCP Vitalife Partners II LP	10% Owner	Sell	S	9.00	6,737	60,639	2,349,511	2.4 M to 2.3 M (-0.29 %)
Nov 30 2015	REPH	Recro Pharma, Inc.	SCP Vitalife Partners II LP	10% Owner	Sell	S	9.00	4,648	41,832	2,356,248	2.4 M to 2.4 M (-0.20 %)
Nov 25 2015	REPH	Recro Pharma, Inc.	SCP Vitalife Partners II LP	10% Owner	Sell	S	9.01	2,068	18,624	2,360,896	2.4 M to 2.4 M (-0.09 %)
Nov 25 2015	REPH	Recro Pharma, Inc.	SCP Vitalife Partners II LP	10% Owner	Sell	S	9.00	11,082	99,748	2,362,964	2.4 M to 2.4 M (-0.47 %)
Nov 25 2015	REPH	Recro Pharma, Inc.	SCP Vitalife Partners (Israel) ...	10% Owner	Sell	S	9.01	691	6,223	788,847	789.5 K to 788.8 K (-0.09 %)
Nov 25 2015	REPH	Recro Pharma, Inc.	SCP Vitalife Partners (Israel) ...	10% Owner	Sell	S	9.00	3,702	33,321	789,538	793.2 K to 789.5 K (-0.47 %)
Sep 08 2015	REPH	Recro Pharma, Inc.	Flynn Karen	Director	Option Exercise	A	13.89	20,000	277,800	20,000
Jul 09 2015	REPH	Recro Pharma, Inc.	Broadfin Healthcare Master Fun ...	10% Owner	Buy	P	11.60	646,553	7,500,015	2,060,086	1.4 M to 2.1 M (+45.74 %)
Jun 09 2015	REPH	Recro Pharma, Inc.	HENWOOD GERALDINE	President and CEO	Buy	P	9.56	550	5,258	104,500	104 K to 104.5 K (+0.53 %)
Jun 09 2015	REPH	Recro Pharma, Inc.	HENWOOD GERALDINE	President and CEO	Buy	P	8.83	3,950	34,879	103,950	100 K to 104 K (+3.95 %)
Jun 09 2015	REPH	Recro Pharma, Inc.	Garner Charles	CFO and Chief Busin ...	Buy	P	8.50	2,000	17,000	5,000	3 K to 5 K (+66.67 %)
Dec 19 2014	REPH	Recro Pharma, Inc.	Ashton William	Director	Option Exercise	A	2.47	22,000	54,340	22,000
Dec 19 2014	REPH	Recro Pharma, Inc.	LUDOMIRSKI ABRAHAM	Director	Option Exercise	A	2.47	22,000	54,340	22,000
Dec 19 2014	REPH	Recro Pharma, Inc.	Garner Charles	CFO and Chief Busin ...	Option Exercise	A	2.47	23,000	56,810	23,000
Dec 19 2014	REPH	Recro Pharma, Inc.	Garner Charles	CFO and Chief Busin ...	Option Exercise	A	2.47	23,000	56,810	23,000
Dec 19 2014	REPH	Recro Pharma, Inc.	Mack Randall	Senior VP, Developm ...	Option Exercise	A	2.47	19,000	46,930	19,000
Dec 19 2014	REPH	Recro Pharma, Inc.	Mack Randall	Senior VP, Developm ...	Option Exercise	A	2.47	19,000	46,930	19,000
Dec 19 2014	REPH	Recro Pharma, Inc.	CHURCHILL WINSTON J	Director	Option Exercise	A	2.47	22,000	54,340	22,000
Dec 19 2014	REPH	Recro Pharma, Inc.	Weisman Wayne	Director	Option Exercise	A	2.47	22,000	54,340	22,000
Dec 19 2014	REPH	Recro Pharma, Inc.	Myers Diane	Senior VP-Reg/Quali ...	Option Exercise	A	2.47	18,000	44,460	18,000
Dec 19 2014	REPH	Recro Pharma, Inc.	Myers Diane	Senior VP-Reg/Quali ...	Option Exercise	A	2.47	18,000	44,460	18,000
Dec 19 2014	REPH	Recro Pharma, Inc.	Berelowitz Michael	Director	Option Exercise	A	2.47	22,000	54,340	22,000
Dec 19 2014	REPH	Recro Pharma, Inc.	Nichols Donna	CAO/Controller	Option Exercise	A	2.47	10,500	25,935	10,500
Dec 19 2014	REPH	Recro Pharma, Inc.	Nichols Donna	CAO/Controller	Option Exercise	A	2.47	10,500	25,935	10,500
Dec 19 2014	REPH	Recro Pharma, Inc.	ALTOMARI ALFRED	Director	Option Exercise	A	2.47	22,000	54,340	22,000
Dec 19 2014	REPH	Recro Pharma, Inc.	HENWOOD GERALDINE	President and CEO	Option Exercise	A	2.47	123,500	305,045	123,500
Dec 19 2014	REPH	Recro Pharma, Inc.	HENWOOD GERALDINE	President and CEO	Option Exercise	A	2.47	123,500	305,045	123,500
Dec 04 2014	REPH	Recro Pharma, Inc.	Broadfin Healthcare Master Fun ...	10% Owner	Buy	P	2.50	241,338	603,345	1,413,533	1.2 M to 1.4 M (+20.59 %)
May 15 2014	REPH	Recro Pharma, Inc.	Garner Charles	CFO and Chief Busin ...	Buy	P	6.69	3,000	20,070	3,000	0 to 3 K
May 15 2014	REPH	Recro Pharma, Inc.	Nichols Donna	CAO/Controller	Buy	P	6.66	1,200	7,992	1,200	0 to 1.2 K
Apr 09 2014	REPH	Recro Pharma, Inc.	Nichols Donna	CAO/Controller	Option Exercise	A	7.00	20,000	140,000	20,000
Apr 09 2014	REPH	Recro Pharma, Inc.	Myers Diane	Senior VP-Reg./Qual ...	Option Exercise	A	7.00	10,000	70,000	10,000
Apr 09 2014	REPH	Recro Pharma, Inc.	Garner Charles	CFO and Chief Busin ...	Option Exercise	A	7.00	34,474	241,318	34,474
Apr 09 2014	REPH	Recro Pharma, Inc.	Mack Randall	Senior VP, Developm ...	Option Exercise	A	7.00	20,000	140,000	20,000
Apr 09 2014	REPH	Recro Pharma, Inc.	HENWOOD GERALDINE	President and CEO	Option Exercise	A	7.00	40,000	280,000	40,000
Mar 13 2014	REPH	Recro Pharma, Inc.	CHURCHILL WINSTON J	Director	Option Exercise	C	5.00	1,875,000	9,375,000	0
Mar 13 2014	REPH	Recro Pharma, Inc.	CHURCHILL WINSTON J	Director	Option Exercise	A	8.00	20,000	160,000	20,000
Mar 13 2014	REPH	Recro Pharma, Inc.	CHURCHILL WINSTON J	Director	Buy	C	0.00	2,045,738	0	3,167,286	1.1 M to 3.2 M (+182.40 %)
Mar 13 2014	REPH	Recro Pharma, Inc.	CHURCHILL WINSTON J	Director	Buy	C	0.00	1,121,548	0	1,121,548	0 to 1.1 M
Mar 13 2014	REPH	Recro Pharma, Inc.	Ashton William	Director	Option Exercise	A	8.00	20,000	160,000	20,000
Mar 13 2014	REPH	Recro Pharma, Inc.	Berelowitz Michael	Director	Option Exercise	A	8.00	20,000	160,000	20,000
Mar 13 2014	REPH	Recro Pharma, Inc.	ALTOMARI ALFRED	Director	Option Exercise	A	8.00	20,000	160,000	20,000
Mar 13 2014	REPH	Recro Pharma, Inc.	SCP Vitalife Partners (Israel) ...	10% Owner	Option Exercise	C	5.00	469,469	2,347,345	0
Mar 13 2014	REPH	Recro Pharma, Inc.	SCP Vitalife Partners (Israel) ...	10% Owner	Buy	C	0.00	512,414	0	793,240	280.8 K to 793.2 K (+182.47 %)
Mar 13 2014	REPH	Recro Pharma, Inc.	SCP Vitalife Partners (Israel) ...	10% Owner	Buy	C	0.00	280,826	0	280,826	0 to 280.8 K
Mar 13 2014	REPH	Recro Pharma, Inc.	LUDOMIRSKI ABRAHAM	Director	Option Exercise	C	5.00	1,875,000	9,375,000	0
Mar 13 2014	REPH	Recro Pharma, Inc.	LUDOMIRSKI ABRAHAM	Director	Option Exercise	A	8.00	20,000	160,000	20,000
Mar 13 2014	REPH	Recro Pharma, Inc.	LUDOMIRSKI ABRAHAM	Director	Buy	C	0.00	2,045,738	0	3,167,286	1.1 M to 3.2 M (+182.40 %)
Mar 13 2014	REPH	Recro Pharma, Inc.	LUDOMIRSKI ABRAHAM	Director	Buy	C	0.00	1,121,548	0	1,121,548	0 to 1.1 M
Mar 13 2014	REPH	Recro Pharma, Inc.	Garner Charles	CFO and Chief Busin ...	Option Exercise	A	8.00	81,026	648,208	81,026
Mar 13 2014	REPH	Recro Pharma, Inc.	Nichols Donna	CAO/Controller	Option Exercise	A	8.00	8,000	64,000	8,000
Mar 13 2014	REPH	Recro Pharma, Inc.	HENWOOD GERALDINE	President and CEO	Option Exercise	A	8.00	60,000	480,000	60,000
Mar 13 2014	REPH	Recro Pharma, Inc.	Myers Diane	Senior VP-Reg./Qual ...	Option Exercise	A	8.00	12,000	96,000	12,000
Mar 13 2014	REPH	Recro Pharma, Inc.	Weisman Wayne	Director	Option Exercise	C	5.00	1,875,000	9,375,000	0
Mar 13 2014	REPH	Recro Pharma, Inc.	Weisman Wayne	Director	Option Exercise	A	8.00	20,000	160,000	20,000
Mar 13 2014	REPH	Recro Pharma, Inc.	Weisman Wayne	Director	Buy	C	0.00	2,045,738	0	3,167,286	1.1 M to 3.2 M (+182.40 %)
Mar 13 2014	REPH	Recro Pharma, Inc.	Weisman Wayne	Director	Buy	C	0.00	1,121,548	0	1,121,548	0 to 1.1 M
Mar 13 2014	REPH	Recro Pharma, Inc.	SCP Vitalife Partners II LP	10% Owner	Option Exercise	C	5.00	1,405,531	7,027,655	0
Mar 13 2014	REPH	Recro Pharma, Inc.	SCP Vitalife Partners II LP	10% Owner	Buy	C	0.00	1,533,324	0	2,374,046	840.7 K to 2.4 M (+182.38 %)
Mar 13 2014	REPH	Recro Pharma, Inc.	SCP Vitalife Partners II LP	10% Owner	Buy	C	0.00	840,722	0	840,722	0 to 840.7 K
Mar 13 2014	REPH	Recro Pharma, Inc.	Mack Randall	Senior VP, Developm ...	Option Exercise	A	8.00	20,000	160,000	20,000

Page: < prev 1 2 3